Advertisement
U.S. markets open in 7 hours 46 minutes

SIGA Technologies, Inc. (SIGA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
7.95+0.62 (+8.46%)
At close: 04:00PM EDT
7.96 +0.01 (+0.13%)
After hours: 07:36PM EDT
  • Dividend

    SIGA announced a cash dividend of 0.60 with an ex-date of Mar. 25, 2024

SIGA Technologies, Inc.

31 East 62nd Street
New York, NY 10065
United States
212 672 9100
https://www.siga.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees45

Key Executives

NameTitlePayExercisedYear Born
Mr. Daniel J. LuckshireExecutive VP, CFO & Secretary1.38MN/A1971
Dr. Dennis E. HrubyExecutive VP & Chief Scientific Officer1.41MN/A1952
Dr. Jay K. Varma M.D.Executive VP, Chief Medical Officer & Director6.24kN/A1972
Dr. Diem Nguyen M.B.A., Ph.D.CEO & DirectorN/AN/A1973
Ms. Tove C. BolkenSenior VP of Operations & Chief Supply Chain OfficerN/AN/AN/A
Mr. Herb VloedmanSenior VP & Chief Information OfficerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Corporate Governance

SIGA Technologies, Inc.’s ISS Governance QualityScore as of March 1, 2024 is 7. The pillar scores are Audit: 8; Board: 9; Shareholder Rights: 2; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.